Adani Energy Solutions Q3 FY2026 Consolidated Net Profit at ₹574.06 Crores

Adani Energy Solutions (AESL) announced its consolidated financial results for Q3 FY2026. The company reported a net profit of ₹574.06 crores and total revenue of ₹6,729.65 crores. AESL also reported significant developments in its transmission and distribution segments, alongside key strategic initiatives. The board approved these results on January 22, 2026.

Financial Performance Highlights

Adani Energy Solutions (AESL) announced strong consolidated financial results for the third quarter of fiscal year 2026. Key figures include:

  • Revenue from Operations: ₹6,729.65 crores
  • Other Income: ₹214.79 crores
  • Total Income: ₹6,944.44 crores
  • Net Profit: ₹574.06 crores

These results reflect the company’s robust performance across its transmission and distribution segments during the quarter, which ended on December 31, 2025.

Segment-Wise Performance

A breakdown of segment-wise revenue for Q3 FY26 is as follows:

  • Transmission: ₹2,426.36 crores
  • Distribution: ₹3,103.62 crores

Key Developments

The company stated that it is complying with the new labor laws which have been consolidated into a united framework comprising 4 Labor Codes effective from November 21, 2025, though the supporting rules are yet to be notified. AESL has assessed the impact, recognizing financial implications amounting to ₹92.95 crores in the statement of profit and loss for the current quarter.

Dahanu Thermal Power Plant Divestment

Adani Electricity Mumbai Limited (AEML), a subsidiary, divested the Dahanu Thermal Power Plant to honor its ESG Commitment. AEML’s Board approved the transaction on July 24, 2024, for a transaction price of ₹815.00 crores, with an exceptional item charge of ₹1,506.02 crores.

Disclaimer Regarding U.S. Legal Matters

AESL has stated that an ongoing legal matter in the United States involving a non-executive director does not impact the company and its financial results.

Source: BSE

Previous Article

Viyash Scientific Partnership with Boehringer Ingelheim to Expand Animal Portfolio

Next Article

Cyient DLM Revised Investor Presentation for Quarter Ended December 2025